Related Experiment Video
Updated: Nov 26, 2025
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine
Maite Sainz-Mejías1, Irene Jurado-Martín1, Siobhán McClean1
1School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland.
Insights
Developing vaccines against Pseudomonas aeruginosa, a major cause of difficult-to-treat infections, is challenging. Research suggests a mixed Th1/Th17 immune response and effective adjuvants are key for successful Pseudomonas aeruginosa vaccines.
Area of Science:
- Microbiology and Immunology
- Vaccine Development
- Infectious Diseases
Background:
- Pseudomonas aeruginosa is a significant pathogen causing chronic respiratory infections in cystic fibrosis, bronchiectasis, and COPD patients, as well as acute infections in immunocompromised individuals.
- Antimicrobial resistance in P. aeruginosa necessitates alternative strategies like vaccines, despite over 50 years of research yielding no licensed products.
- Understanding P. aeruginosa biology and host immune responses is crucial for effective vaccine design.
Purpose of the Study:
- To review the current state of Pseudomonas aeruginosa vaccine development.
- To analyze the complexities of P. aeruginosa-host interactions influencing vaccine design.
- To identify future directions for P. aeruginosa vaccine research.
Main Methods:
- Comprehensive literature review of P. aeruginosa-host interactions.
- Analysis of immunological responses to P. aeruginosa antigens.
- Evaluation of various antigens and adjuvants in vaccine strategies.
Main Results:
- A polarized Th2 immune response is suboptimal for protection against P. aeruginosa.
- A mixed Th1/Th2 or Th1/Th17 immune response appears more beneficial.
- The selection of appropriate adjuvants is critical for enhancing protective efficacy.
Conclusions:
- Despite challenges, advances in understanding host immunity and pathogen biology offer new avenues for P. aeruginosa vaccine development.
- Future vaccine strategies should focus on eliciting mixed Th1/Th17 responses and incorporating effective adjuvants.
- Optimizing vaccine design requires a deep understanding of P. aeruginosa-host immune dynamics.
Abstract:
Pseudomonas aeruginosa is a leading cause of chronic respiratory infections in people with cystic fibrosis (CF), bronchiectasis or chronic obstructive pulmonary disease (COPD), and acute infections in immunocompromised individuals. The adaptability of this opportunistic pathogen has hampered the development of antimicrobial therapies, and consequently, it remains a major threat to public health. Due to its antimicrobial resistance, vaccines represent an alternative strategy to tackle the pathogen, yet despite over 50 years of research on anti-Pseudomonas vaccines, no vaccine has been licensed. Nevertheless, there have been many advances in this field, including a better understanding of the host immune response and the biology of P. aeruginosa. Multiple antigens and adjuvants have been investigated with varying results. Although the most effective protective response remains to be established, it is clear that a polarised Th2 response is sub-optimal, and a mixed Th1/Th2 or Th1/Th17 response appears beneficial. This comprehensive review collates the current understanding of the complexities of P. aeruginosa-host interactions and its implication in vaccine design, with a view to understanding the current state of Pseudomonal vaccine development and the direction of future efforts. It highlights the importance of the incorporation of appropriate adjuvants to the protective antigen to yield optimal protection.
More Related Videos
Related Concept Videos
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...